Exosomal miRNAs as cancer biomarkers and therapeutic targets

References

• [PubMed CentralFull Text] Bruecher BL, Jamall IS. Cell-cell communication in the tumor microenvironment, carcinogenesis, and anticancer treatment. Cell Physiol Biochem. 2014;34:213–43..
   Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646–74. [PubMed Abstract].
   Google Scholar
• Sceneay J, Smyth MJ, Möller A. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev. 2013; 32: 449–64. [PubMed Abstract].
   Google Scholar
• Tickner JA, Urquhart AJ, Stephenson SA, Richard DJ, O'Byrne KJ. Functions and therapeutic roles of exosomes in cancer. Front Oncol. 2014; 4: 3389.
   Google Scholar
• Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9: 654–9. [PubMed Abstract].
   Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281–97. [PubMed Abstract].
   Google Scholar
• Zhang B, Pan X, Cobb GP, Anderson TA. MicroRNAs as oncogenes and tumor suppressors. Dev. Biol. 2007; 302: 1–2. [PubMed Abstract].
   Google Scholar
• Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008; 110: 13–21. [PubMed Abstract].
   Google Scholar
• Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, etal. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA. 2016; 113: 968–77. doi: http://dx.doi.org/10.1073/pnas.1521230113.
   Google Scholar
• Minciacchi VR, Freeman MR, Di Vizio D. Extracellular vesicles in cancer: exosomes, microvesicles and the emerging role of large oncosomes. Semin Cell Dev Biol. 2015; 40: 41–51. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Perkins GL, Slater ED, Sanders GK, Prichard JG. Serum tumor markers. Am Fam Physician. 2003; 68: 1075–88. [PubMed Abstract].
   Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, Ruf IK, Pritchard CC, Gibson DF, etal. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA. 2011; 108: 5003–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Weber JA, Baxter DH, Zhang S, Huang DY, Huang KH, Lee MJ, etal. The microRNA spectrum in 12 body fluids. Clin Chem. 2010; 56: 1733–41. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z. MiRNA in plasma exosome is stable under different storage conditions. Molecules. 2014; 19: 1568–75. [PubMed Abstract].
   Google Scholar
• Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, etal. Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem. 2012; 287(6): 3842–9. [PubMed Abstract].
   Google Scholar
• Lau C, Kim Y, Chia D, Spielmann N, Eibl G, Elashoff D, etal. Role of pancreatic cancer-derived exosomes in salivary biomarker development. J Biol Chem. 2013; 288: 26888–97. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ben-Dov IZ, Brown M, Whalen VM, Tuschl T. 30 Profiling urine cell and exosome microRNA using a barcoded small RNA deep sequencing approach. Am J Kidney Dis. 2011; 57: B24.
   Web of Science ®Google Scholar
• Koga Y, Yasunaga M, Moriya Y, Akasu T, Fujita S, Yamamoto S, etal. Exosome can prevent RNase from degrading microRNA in feces. J Gastrointest Oncol. 2011; 2: 215–22. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999; 94: 3791–9. [PubMed Abstract].
   Google Scholar
• Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, Garin J, etal. Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol. 2001; 166: 7309–18.
   PubMed Web of Science ®Google Scholar
• Gruenberg J, Maxfield FR. Membrane transport in the endocytic pathway. Curr Opin Cell Biol. 1995; 7: 552–63. [PubMed Abstract].
   Google Scholar
• Van Deun J, Mestdagh P, Sormunen R, Cocquyt V, Vermaelen K, Vandesompele J, etal. The impact of disparate isolation methods for extracellular vesicles on downstream RNA profiling. J Extracell Vesicles. 2014; 3: 24858, doi: http://dx.doi.org/10.3402/jev.v3.24858 [PubMed CentralFull Text].
   Google Scholar
• Rekker K, Saare M, Roost AM, Kubo AL, Zarovni N, Chiesi A, etal. Comparison of serum exosome isolation methods for microRNA profiling. Clin Biochem. 2014; 47: 135–8. [PubMed Abstract].
   Google Scholar
• Rupp AK, Rupp C, Keller S, Brase JC, Ehehalt R, Fogel M, etal. Loss of EpCAM expression in breast cancer derived serum exosomes: role of proteolytic cleavage. Gynecol Oncol. 2011; 122: 437–46. [PubMed Abstract].
   Google Scholar
• Kalra H, Adda CG, Liem M, Ang CS, Mechler A, Simpson RJ, etal. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics. 2013; 13: 3354–64. [PubMed Abstract].
   Google Scholar
• Hong CS, Funk S, Muller L, Boyiadzis M, Whiteside TL. Isolation of biologically active and morphologically intact exosomes from plasma of patients with cancer. J Extracell Vesicles. 2016; 24: 5.
   Google Scholar
• Baranyai T, Herczeg K, Onódi Z, Voszka I, Módos K, Marton N, etal. Isolation of exosomes from blood plasma: qualitative and quantitative comparison of ultracentrifugation and size exclusion chromatography methods. PLoS One. 2015; 10: e0145686. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Welton JL, Webber JP, Botos LA, Jones M, Clayton A. Ready-made chromatography columns for extracellular vesicle isolation from plasma. J Extracell Vesicles. 2015; 4: 27269, doi: http://dx.doi.org/10.3402/jev.v4.27269.
   Google Scholar
• Kanwar SS, Dunlay CJ, Simeone DM, Nagrath S. Microfluidic device (ExoChip) for on-chip isolation, quantification and characterization of circulating exosomes. Lab Chip. 2014; 14: 1891–900. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• He M, Crow J, Roth M, Zeng Y, Godwin AK. Integrated immunoisolation and protein analysis of circulating exosomes using microfluidic technology. Lab Chip. 2014; 14: 3773–80. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Chen C, Skog J, Hsu CH, Lessard RT, Balaj L, Wurdinger T, etal. Microfluidic isolation and transcriptome analysis of serum microvesicles. Lab Chip. 2010; 10: 505–11. [PubMed Abstract].
   Google Scholar
• Wang Z, Wu HJ, Fine D, Schmulen J, Hu Y, Godin B, etal. Ciliated micropillars for the microfluidic-based isolation of nanoscale lipid vesicles. Lab Chip. 2013; 13: 2879–82. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Im H, Shao H, Park YI, Peterson VM, Castro CM, Weissleder R, etal. Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor. Nat Biotechnol. 2014; 32: 490. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Zhao JJ, Hua YJ, Sun DG, Meng XX, Xiao HS, Ma X. Genome-wide microRNA profiling in human fetal nervous tissues by oligonucleotide microarray. Childs Nerv Syst. 2006; 22: 1419–25. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Mestdagh P, Hartmann N, Baeriswyl L, Andreasen D, Bernard N, Chen C, etal. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014; 11: 809–15. [PubMed Abstract].
   Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, etal. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Nat Acad of Sci USA. 2008; 105: 10513–8.
   PubMed Web of Science ®Google Scholar
• Rocci A, Hofmeister CC, Geyer S, Talabere T, Gambella M, Cascione L, etal. Circulating Mir-16 and Mir-25 as new prognosticators for multiple myeloma. Blood. 2013; 122: 1853.
   Google Scholar
• Filková M, Aradi B, Šenolt L, Ospelt C, Vettori S, Mann H, etal. Association of circulating miR-223 and miR-16 with disease activity in patients with early rheumatoid arthritis. Ann Rheum Dis. 2014; 73: 1898–904.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Lee EJ, Jiang J, Sarkar A, Yang L, Elton TS, etal. Real-time PCR quantification of precursor and mature microRNA. Methods. 2008; 44: 31–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Rani S, O'Brien K, Kelleher FC, Corcoran C, Germano S, Radomski MW, etal. Isolation of exosomes for subsequent mRNA, MicroRNA, and protein profiling. Methods Mol Biol. 2011; 784: 181–95. [PubMed Abstract].
   Google Scholar
• Pigati L, Yaddanapudi SC, Iyengar R, Kim DJ, Hearn SA, Danforth D, etal. Selective release of microRNA species from normal and malignant mammary epithelial cells. PLoS One. 2010; 5: e13515. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Lee LW, Zhang S, Etheridge A, Ma L, Martin D, Galas D, etal. Wang K. Complexity of the microRNA repertoire revealed by next-generation sequencing. RNA. 2010; 16: 2170–80. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Behjati S, Tarpey PS. What is next generation sequencing?. Arch Dis Child Educ Pract Ed. 2013; 98: 236–8. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Wyman SK, Parkin RK, Mitchell PS, Fritz BR, O'Briant K, Godwin AK, etal. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS One. 2009; 4: e5311. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Rabinowits G, Gerçel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009; 10: 42–6. [PubMed Abstract].
   Google Scholar
• Nilsson J, Skog J, Nordstrand A, Baranov V, Mincheva-Nilsson L, Breakefield XO, etal. Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer. Br J Cancer. 2009; 100: 1603–7. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival. Clin Med Res. 2009; 7: 4–13. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF, Dunning MJ, etal. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype. Genome Biol. 2007; 8: R214. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Eichelser C, Stückrath I, Müller V, Milde-Langosch K, Wikman H, Pantel K, etal. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Oncotarget. 2014; 5: 9650. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Tanaka Y, Kamohara H, Kinoshita K, Kurashige J, Ishimoto T, Iwatsuki M, etal. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer. 2013; 119: 1159–67. [PubMed Abstract].
   Google Scholar
• Que R, Ding G, Chen J, Cao L. Analysis of serum exosomal microRNAs and clinicopathologic features of patients with pancreatic adenocarcinoma. World J Surg Oncol. 2013; 11: 1.
   Web of Science ®Google Scholar
• Camacho L, Guerrero P, Marchetti D. MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PLoS One. 2013; 8: e73790. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Frères P, Josse C, Bovy N, Boukerroucha M, Struman I, Bours V, etal. Chemotherapy in breast cancer patients induces miR-34a and miR-122 expression. J Cell Physiol. 2015; 230: 473–81.
   Web of Science ®Google Scholar
• Shapira I, Lee A, Oswald M, Parameswaran J, Sultan K, Budman D. Surgical and chemotherapy influence on circulating developmental microRNA miR17-92 and long term survival in breast and ovarian cancer patients. Cancer Res. 2013; 73(Suppl 8): 1843.
   Google Scholar
• Bovy N, Blomme B, Frères P, Dederen S, Nivelles O, Lion M, etal. Endothelial exosomes contribute to the antitumor response during breast cancer neoadjuvant chemotherapy via microRNA transfer. Oncotarget. 2015; 6: 10253–66. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Hornick NI, Huan J, Doron B, Goloviznina NA, Lapidus J, Chang BH, etal. Serum exosome microRNA as a minimally-invasive early biomarker of AML. Sci Rep. 2015; 5: 11295. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Arscott WT, Tandle AT, Zhao S, Shabason JE, Gordon IK, Schlaff CD, etal. Ionizing radiation and glioblastoma exosomes: implications in tumor biology and cell migration. Transl Oncol. 2013; 6: 638–48. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Logozzi M, De Milito A, Lugini L, Borghi M, Calabro L, Spada M, etal. High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients. PLoS One. 2009; 4: e5219. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Corcoran C, Rani S, O'Driscoll L. MiR-34a is an intracellular and exosomal predictive biomarker for response to docetaxel with clinical relevance to prostate cancer progression. Prostate. 2014; 74: 1320–34. [PubMed Abstract].
   Google Scholar
• Huang X, Yuan T, Liang M, Du M, Xia S, Dittmar R, etal. Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer. Eur Urol. 2015; 67: 33–41. [PubMed Abstract].
   Google Scholar
• Takeshita N, Hoshino I, Mori M, Akutsu Y, Hanari N, Yoneyama Y, etal. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 2013; 108: 644–52. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Johnstone RM, Bianchini A, Teng K. Reticulocyte maturation and exosome release: transferrin receptor containing exosomes shows multiple plasma membrane functions. Blood. 1989; 74: 1844–51. [PubMed Abstract].
   Google Scholar
• Ohshima K, Inoue K, Fujiwara A, Hatakeyama K, Kanto K, Watanabe Y, etal. Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line. PLoS One. 2010; 5: e13247. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ostenfeld MS, Jeppesen DK, Laurberg JR, Boysen AT, Bramsen JB, Primdal-Bengtson B, etal. Cellular disposal of miR23b by RAB27-dependent exosome release is linked to acquisition of metastatic properties. Cancer Res. 2014; 74: 5758–71. [PubMed Abstract].
   Google Scholar
• Chevillet JR, Kang Q, Ruf IK, Briggs HA, Vojtech LN, Hughes SM, etal. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Nat Acad Sci USA. 2014; 111: 14888–93. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Fabbri M, Paone A, Calore F, Galli R, Gaudio E, Santhanam R, etal. MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Nat Acad Sci. 2012; 109: E2110–6. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Chuang JC, Jones PA. Epigenetics and microRNAs. Pediatr Res. 2007; 61: 24R–9R. [PubMed Abstract].
   Google Scholar
• Singh R, Pochampally R, Watabe K, Lu Z, Mo YY. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Mol cancer. 2014; 13: 256. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Umezu T, Ohyashiki K, Kuroda M, Ohyashiki JH. Leukemia cell to endothelial cell communication via exosomal miRNAs. Oncogene. 2013; 32: 2747–55. [PubMed Abstract].
   Google Scholar
• Umezu T, Tadokoro H, Azuma K, Yoshizawa S, Ohyashiki K, Ohyashiki JH. Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1. Blood. 2014; 124: 3748–57. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ye SB, Li ZL, Luo DH, Huang BJ, Chen YS, Zhang XS, etal. Tumor-derived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget. 2014; 5: 5439–52. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, Li P, etal. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015; 527: 100–4. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Kosaka N, Iguchi H, Hagiwara K, Yoshioka Y, Takeshita F, Ochiya T. Neutral sphingomyelinase 2 (nSMase2)-dependent exosomal transfer of angiogenic microRNAs regulate cancer cell metastasis. J Biol Chem. 2013; 288: 10849–59. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Yang M, Chen J, Su F, Yu B, Su F, Lin L, etal. Microvesicles secreted by macrophages shuttle invasion-potentiating microRNAs into breast cancer cells. Mol Cancer. 2011; 10: 1.
   Web of Science ®Google Scholar
• Ridder K, Sevko A, Heide J, Dams M, Rupp AK, Macas J, etal. Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment. Oncoimmunology. 2015; 4: e1008371. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Zomer A, Maynard C, Verweij FJ, Kamermans A, Schäfer R, Beerling E, etal. In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior. Cell. 2015; 161: 1046–57. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Marleau AM, Chen CS, Joyce JA, Tullis RH. Exosome removal as a therapeutic adjuvant in cancer. J Transl Med. 2012; 10: 134. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Henne WM, Buchkovich NJ, Emr SD. The ESCRT pathway. Dev Cell. 2011; 21: 77–91. [PubMed Abstract].
   Google Scholar
• Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, etal. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008; 319: 1244–7. [PubMed Abstract].
   Google Scholar
• Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, etal. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nat Cell Biol. 2010; 12: 19–30. [PubMed Abstract].
   Google Scholar
• Villarroya-Beltri C, Gutiérrez-Vázquez C, Sánchez-Cabo F, Pérez-Hernández D, Vázquez J, Martin-Cofreces N, etal. Sumoylated hnRNPA2B1 controls the sorting of miRNAs into exosomes through binding to specific motifs. Nat Commun. 2013; 4: 2980. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, etal. Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell. 2014; 26: 707–21. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Bobrie A, Colombo M, Raposo G, Théry C. Exosome secretion: molecular mechanisms and roles in immune responses. Traffic. 2011; 12: 1659–68. [PubMed Abstract].
   Google Scholar